24/7 Wall St. » REGN

Top Analyst Upgrades & Downgrades (AET, AEM, APD, ALU, MDRX, AMZN, AMCC, BIDU, CBG, CTCT, DECK, EBAY, LOGI, PCS, PM, REGN, SNDK, STX, WDC, ZNGA)

Administrator — Fri, 27 Apr 2012 12:17:32 +0000

These are some of the top analyst upgrades, downgrades and initiations seen in Wall Street research calls this Friday.

Aetna Inc. (NYSE: AET) Reiterated Buy with a target price of $55 at Argus.

Agnico-Eagle Mines Limited (NYSE: AEM) Raised to Outperform at Credit Suisse.

Air Products & Chemicals Inc. (NYSE: APD) Cut to Neutral at Citigroup.

Alcatel-Lucent SA (NYSE: ALU) Maintained Underperform and cut estimates at Jefferies.

Allscripts Healthcare (NASDAQ: MDRX) Cut to Neutral at Credit Suisse; Cut to Equal-weight at Barclays.

Amazon.com Inc. (NASDAQ: AMZN) Raised to Buy at BofA/ML; Raised to Buy at Nomura; Raised to Buy at Goldman Sachs; Maintained Hold but raised target to $230 at Canaccord Genuity.

Applied Micro Circuits Corp. (NASDAQ: AMCC) Cut to Hold at Wunderlich.

Baidu, Inc. (NASDAQ: BIDU) Maintained Neutral but target cut at Credit Suisse.

CBRE Group, Inc. (NYSE: CBG) named Bull of the Day at Zacks.

Constant Contact (NASDAQ: CTCT) Cut to Neutral at Janney; Cut to Market Perform William Blair.

Deckers Outdoor Corp. (NASDAQ: DECK) Cut to Hold at Jefferies; Cut to Hold at Canaccord Genuity.

eBay Inc. (NASDAQ: EBAY) Reiterated Buy and raised target to $48 from $40 at Argus.

Logitech International (NASDAQ: LOGI) Raised to Outperform at BNP Paribas.

MetroPCS (NYSE: PCS) Cut to Hold at Argus; Cut to Hold at Deutsche Bank; Cut to Hold at Canaccord Genuity.

Philip Morris International Inc. (NYSE: PM) Reiterated Buy and raised target to $94 from $88 at Argus.

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) Cut to Market Perform at BMO.

SanDisk Corporation (NASDAQ: SNDK) Raised to Buy at Jefferies.

Seagate Technology PLC (NASDAQ: STX) Cut to Neutral at BofA/ML.

Western Digital Corporation (NYSE: WDC) Cut to Neutral at BofA/ML.

Zynga, Inc. (NASDAQ: ZNGA) Raised to Neutral at BofA/ML; Raised to Overweight at JPMorgan; Maintained Hold but cut target to $13 from $15 at Canaccord Genuity.

AAR Corporation (NYSE: AIR) named Bear of the Day at Zacks.

If you enjoyed the top analyst upgrades and downgrades, you can join our free email newsletter that includes analyst summaries each morning sent right to your inbox. We also cover top issues such as IPOs, special financial exclusives, mergers and more. Sign up in the box below.

JON C. OGG

Filed under: Analyst Calls Tagged: AEM, AET, ALU, AMCC, AMZN, APD, BIDU, CBG, CTCT, DECK, EBAY, LOGI, MDRX, PCS, PM, REGN, SNDK, STX, WDC, ZNGA

24/7 Wall St. Closing Bell (GD, ABB, HOG, COP, S, ALU, MO, PEP, TLAB, XOM, AET, BMY, BG, JBLU, LIZ, MJN, REGN, SWY, SWC, TASR, UPS, YNDX, NRGY, SPH, LEAP, AKAM)

Paul Ausick — Thu, 26 Apr 2012 20:06:31 +0000

Markets opened a few ticks lower this morning after a poor report on new claims for unemployment benefits in the US (our coverage here). The report that pending home sales jumped 4.1% lit a fire under investors and pushed equities higher (our coverage here). The EIA report on natural gas supplies held gas prices higher although they’ve dropped back by late afternoon (our coverage here). Yields on 7-year US Treasury notes were at a record low following Fed Chairman Ben Bernanke’s clarification of what “exceptionally low” interest rates mean (our coverage here). The US dollar index fell today, now down -0.17% at 78.932. The GSCI commodity index is up 0.04% at 677.57, with commodities mixed on the slightly weaker dollar. WTI crude oil closed up 0.4% at $104.55/barrel, and Brent crude trades up 0.65% at $119.89/barrel. Gold settled up 1.1% today, at $1,660.50/ounce.

The unofficial closing bells put the DJIA up nearly 114 points to 13,204.70 (0.87%), the NASDAQ rose nearly 21 points (0.69%) to 3,050.61, and the S&P 500 rose 0.67% or more than 9 points to 1,399.99.

There were several analyst upgrades and downgrades today, including General Dynamics Corp. (NYSE: GD) cut to ‘equal-weight’ at Morgan Stanley; ABB Ltd. (NYSE: ABB) cut to ‘neutral’ at JPMorgan; Harley-Davidson Inc. (NYSE: HOG) raised to ‘overweight’ at Barclays; ConocoPhillips (NYSE: COP) raised to ‘neutral’ at Macquarie; and Sprint Nextel Corp. (NYSE: S) maintained as ‘hold’ at Argus.

Earnings reports since markets closed last night have led to some price changes as of the last half hour of trading today: Alcatel-Lucent S.A. (NYSE: ALU) is down -16.9% at $19.71 (our coverage here); Altria Group Inc. (NYSE: MO) is up 0.9% at $31.96 (our story here); Pepsico (NYSE: PEP) is down -0.3% at $66.44 (our story here); Tellabs Inc. (NASDAQ: TLAB) is down -5.1% at $3.83 (our coverage here); Exxon Mobil Corp. (NYSE: XOM) is down -0.8% at $86.13 (our coverage here); Aetna Inc. (NYSE: AET) is down -8.4% at $45.22; Bristol-Myers Squibb Co. (NYSE: BMY) is down -1.7% at $33.72; Bunge Ltd. (NYSE: BG) is down -2.6% at $65.69; JetBlue Airways Corp. (NASDAQ: JBLU) is down -0.1% at $4.64; Liz Claiborne Inc. (NYSE: LIZ) is up 9.4% at $13.87; Mead Johnson Nutrition Co. (NYSE: MJN) is up XX% at $XX; Regeneron Pharmaceuticals Inc. (NASDAQ: REGN) is up 4% at $86.38 after posting a new 52-week high of $87.26n earlier today; Safeway Inc. (NYSE: SWY) is down -2.8% at $21.00; Stillwater Mining Co. (NYSE: SWC) is down -4.6% at $10.69; TASER International Inc. (NASDAQ: TASR) is up 5.7% at $4.39; United Parcel Service Inc. (NYSE: UPS) is down -1.8% at $78.25; and Yandex N.V. (NASDAQ: YNDX) is down -5% at $23.31.

Other standouts from today include the following stocks:

Inergy L.P. (NYSE: NRGY) is up 17% at $19.71. The company is being acquired by Suburban Propane Partners LP (NYSE: SPH). More coverage here.

Leap Wireless International Inc. (NASDAQ: LEAP) is down -20.2% at $6.16. The wireless carrier fell sharply on disappointing quarterly results. More coverage here.

Akamai Technologies Inc. (NASDAQ: AKAM) is down -14.8% at $33.03. The technology provider beat estimates but issued weak guidance.

Stay tuned for Friday. We have noted the following events on the schedule (all times Eastern):

8:30 a.m. – GDP report
8:30 a.m. – Employment cost index
9:55 a.m. – Reuters/University of Michigan consumer sentiment index

Paul Ausick

Filed under: HI/LOW, Market Close Tagged: ABB, AET, AKAM, ALU, BG, BMY, COP, GD, HOG, JBLU, LEAP, LIZ, MJN, MO, NRGY, PEP, REGN, S, SPH, SWC, SWY, TASR, TLAB, UPS, XOM, YNDX

24/7 Wall St. Closing Bell (GE, FFIV, GRPN, PGR, REGN, CHKP, COP, DHI, ETN, HAS, PCH, XRX, AMLN, LSI)

Paul Ausick — Mon, 23 Apr 2012 20:04:36 +0000

Markets opened lower this morning following some reversals in Europe, not the least of which is the coming French presidential election. PMI readings from Europe and China were also weak. Asian and European markets were lower across the board today as well. The US dollar index rose today, now up 0.27% at 79.409. The GSCI commodity index is up 0.05% at 676.38, with commodities mixed, though orange juice is down more than -5%. WTI crude oil closed down -1.3% at $102.49/barrel, and Brent crude trades down -0.12% at $118.62/barrel. Gold settled down -0.06% today, at $1,632.60/ounce.

The unofficial closing bells put the DJIA fell more than 102 points to 12,926.86 (-0.79%), the NASDAQ fell 30 points (-1%) to 2,970.45, and the S&P 500 fell -0.84% or more than 11 points to 1,366.94.

There were several analyst upgrades and downgrades today, including General Electric Co. (NYSE: GE) reiterated ‘outperform’ with a $22 target price at Credit Suisse; F5 Networks Inc. (NASDAQ: FFIV) started as ‘overweight’ at Morgan Stanley; Groupon Inc. (NASDAQ: GRPN) raised to ‘overweight’ at Evercore; Progressive Corp. (NYSE: PGR) cut to ‘neutral’ at Citigroup; and Regeneron Pharmaceuticals Inc. (NASDAQ: REGN) reiterated as ‘buy’ and target price raised to $146 at BofA/ML.

Earnings reports since markets closed last Friday have led to some price changes as of the last half hour of trading today: Check Point Software Technologies Ltd. (NASDAQ: CHKP) is down -5.1% at $60.77; ConocoPhillips (NYSE: COP) is down -0.6% at $72.44; D.R. Horton Inc. (NYSE: DHI) is down -2.1% at $15.06 (our coverage here); Eaton Corp. (NYSE: ETN) is down -0.15% at $47.37; Hasbro Inc. (NYSE: HAS) is down -5% at $34.11; Potlach Corp. (NYSE: PCH) is down -1.7% at $30.53; and Xerox Corp. (NYSE: XRX) is up 0.32% at $7.90.

Other standouts from today include the following stocks:

Amylin Pharmaceuticals Inc. (NASDAQ: AMLN) is up 14.2% at $26.17 after posting a new 52-week high this morning of $26.25. The company has hired advisers for a possible sale of the company. More coverage here and here.

LSI Corp. (NYSE: LSI) is up 1% at $8.01. The semiconductor maker got a boost from a story in Barron’s magazine over the weekend. More coverage here.

Stay tuned for Tuesday. The Federal Reserve Open Market Committee begins its two-day meeting. We have noted the following events on the schedule (all times Eastern):

9:00 a.m. – S&P Case-Shiller housing price index
10:00 a.m. – New home sales
10:00 a.m. – Conference board consumer confidence
10:00 a.m. – FHFA house price index
10:00 a.m. – Richmond Fed manufacturing index
11:30 a.m. – 4-week bill auction
1:00 p.m. – 2-year note auction

Paul Ausick

Filed under: HI/LOW, Market Close Tagged: AMLN, CHKP, COP, DHI, ETN, FFIV, GE, GRPN, HAS, LSI, PCH, PGR, REGN, XRX

Top Analyst Upgrades & Downgrades (ARMH, STD, BBVA, PRSS, CBS, DRQ, FFIV, GE, GRPN, MSFT, NSM, PCLN, PGR, REGN)

Administrator — Mon, 23 Apr 2012 11:52:54 +0000

These are some of the top analyst upgrades, downgrades and initiations seen in Wall Street research calls this Monday.

ARM Holdings PLC (NASDAQ: ARMH) Raised to Neutral at JPMorgan.

Banco Santander (NYSE: STD) Added to Conviction Buy List at Goldman Sachs; Raised to Overweight at JPMorgan.

Banco Bilbao Vizcaya Argentaria, S.A. (NYSE: BBVA) maintained Buy but removed from Conviction Buy List at Goldman Sachs.

CafePress Inc. (NASDAQ: PRSS) Started as Buy at Janney

CBS Corporation (NYSE: CBS) named Bull of the Day at Zacks.

Dril-Quip, Inc. (NYSE: DRQ) named Bear of the Day at Zacks.

F5 Networks, Inc. (NASDAQ: FFIV) Started as Overweight at Morgan Stanley.

General Electric Co. (NYSE: GE) Reiterated Outperform with $22 target at Credit Suisse.

Groupon, Inc. (NASDAQ: GRPN) Raised to Overweight at Evercore.

Microsoft Corporation (NASDAQ: MSFT) Reiterated Buy with $39 target at Argus.

Nationstar Mortgage Holdings Inc. (NYSE: NSM) Started as Outperform with $20 target at Credit Suisse; Started as Outperform at Wells Fargo; Started as Buy with $18 target at BofA/ML.

priceline.com Incorporated (NASDAQ: PCLN) Reiterated Outperform and raised target to $811 at Credit Suisse.

Progressive Corp. (NYSE: PGR) Cut to Neutral at Citigroup.

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) Reiterated Buy and raised target to $146 at BofA/ML.

JON C. OGG

Filed under: Analyst Calls Tagged: ARMH, BBVA, CBS, DRQ, FFIV, GE, GRPN, MSFT, NSM, PCLN, PGR, PRSS, REGN, STD

Sanofi, Regeneron Get Positive News from Drug Trials (SNY, REGN)

Paul Ausick — Mon, 26 Mar 2012 15:51:54 +0000

An anti-cholesterol drug being co-developed by Sanofi (NYSE: SNY) and Regeneron Pharmaceuticals Inc. (NASDAQ: REGN) has shown positive results in two Phase II trials the companies reported this morning. The investigational drug, SAR236553/REGN727, reduced levels of LDL-C, or “bad,” cholesterol in 40%-72% of patients who were taking stable doses of statin drugs.

The drug could be important in helping patients reduce cholesterol levels further when they reach the limitations of what a statin drug can do, according to a press release.

The news has boosted Regeneron shares to a new 52-week high of $121.14, up more than 1%. Sanofy’s ADS are also up about 1% at $38.72.

Filed under: Drug companies, Pharmaceuticals Tagged: REGN, SNY

Morning Movers (GNOM, REGN, CHTP, KVHI, BDCO)

Paul Ausick — Mon, 13 Feb 2012 15:39:11 +0000

The three major US equities indexes opened higher this morning as traders respond positively to Greek parliament’s vote to accept additional austerity meausres in exchange for a second $172 bailout package. The DJIA is about up nearly 55 points at about 12,856, the Nasdaq Composite is up more than 25 points at about 2,929, and the S&P 500 is nearly 7 points at about 1,350.

There are several stocks trading more heavily than usual this morning, and also experiencing large gains or drops in share prices. These include Complete Genomics Inc. (NASDAQ: GNOM), Regeneron Pharmaceuticals Inc. (NASDAQ: REGN), Chelsea Therapeutics International Ltd. (NASDAQ: CHTP), KVH Industries Inc. (NASDAQ: KVHI), and Blue Dolphin Energy Co. (NASDAQ: BDCO).

After the first hour of trading this morning, Complete Genomics is up nearly 33% at $4.37. Volume is about already nearly 10x the daily average of about 675,000 shares traded. The DNA-sequencing company has been selected by the Mayo Clinic to supply outsourced whole human genome sequencing.

Regeneron is up about 11% at $113.27 after posting a new 52-week high of $115.50 earlier this morning. Volume is already about 8x the daily average of 615,000 shares traded. The biopharmaceutical company raised its full-year sales forecast.

Chelsea is down more than -34% at $3.28 after posting a new 52-week low of $2.90 earlier. Volume is already about 30x the daily average of about 680,000 shares traded. The development stage pharmaceutical company reported that it would present additional information for its new drug application currently pending before the FDA.

KVH is down nearly -9% at $9.04. Volume is already about half the daily average of around 62,000 shares traded. The mobile communications product maker provided lower-than-expected guidance for 2012 this morning.

Blue Dolphin is up nearly 16% at $5.97. Volume is already more than double the daily average of about 22,000 shares traded. The oil & gas midstream and E&P company sold $300 million of new notes in a private placement last week.

Paul Ausick

Filed under: 24/7 Wall St. Wire Tagged: BDCO, CHTP, GNOM, KVHI, REGN

Tracking Dividends in Biotech: Who Follows Amgen in Payouts? (AMGN, PFE, MRK, BIIB, CELG, ALXN, CBST, PDLI, REGN, VRTX)

Administrator — Wed, 04 Jan 2012 13:01:10 +0000

For several years it has been the case that Amgen Inc. (NASDAQ: AMGN) was considered a biotech though it had at least some of the same problems of Big Pharma players like Pfizer Inc. (NYSE: PFE) and Merck & Co. (NYSE: MRK). The difference is that Amgen refused for ages to pay a dividend. 2011 marked a change in its dividend policy.

Amgen’s current dividend is 2.3%, which is rather high for a biotech stock. It also should be noted that the $64.00 price is above the stock’s old former rangebound levels of $50.00 to $60.00. Pfizer currently yields 3.7%, but that is about to rise to closer to 4%, and Merck yields about 4.50% after its dividend hike.

The question for 2012 is simple: Which biotech stocks will be among the second waves to initiate paying a dividend? By our count, these are the biotech outfits that might entertain following Amgen’s dividend path: Biogen Idec Inc. (NASDAQ: BIIB), Celgene Corporation (NASDAQ: CELG), Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN), Cubist Pharmaceuticals Inc. (NASDAQ: CBST), PDL BioPharma, Inc. (NASDAQ: PDLI), Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN), and Vertex Pharmaceuticals Inc. (NASDAQ: VRTX).

We would have evaluated the chances of Gilead Sciences Inc. (NASDAQ: GILD) initiating a dividend, but this $11 billion proposed buyout of Pharmasset, Inc. (NASDAQ: VRUS) is likely to keep Gilead tied up for quite some time.

Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) is close to all-time highs above $70 and is now worth a whopping $13.2 billion. Estimates are $1.30 EPS for 2011 and $1.66 EPS for 2012, making this one have a much higher valuation while it is still rapidly growing. Some investors may expect that it could start paying out a dividend, but it is too soon by our take today, even with a $445 million balance of cash and liquidity with almost no long-term debt.

Biogen Idec Inc. (NASDAQ: BIIB) has estimates of $5.89 EPS in 2011 and $6.31 EPS in 2012. The company had only about $3 billion in cash and investments at the end of September versus a current market cap of about $27 billion. 2011 was the year that investors decided to give up on worrying about the very rare PML cases in TYSABRI, and that allowed Biogen shares to rise almost 60% in 2011. If Biogen decides to get off the no-dividend bandwagon soon, we would only look for an initial payout of $1.00 on an annualized basis for a while.

Celgene Corporation (NASDAQ: CELG) may still be too new of an earnings story to start expecting a dividend. The earnings estimates are $3.80 EPS in 2011 and $4.51 EPS in 2012. With almost $2.6 billion in cash and investments, its market cap is larger than Biogen’s at $30 billion.

Cubist Pharmaceuticals Inc. (NASDAQ: CBST) managed an incredible breakout year as its drugs treat hospital-borne infections, with nearly a 100% share price gain in 2011. The market cap is now about $2.45 billion, and it had nearly $1 billion in cash and liquidity before a recent $221 million acquisition versus about $450 million in long-term debt. Cubist probably could start to pay a dividend if it wants to, but the company has decided to be an acquirer rather than hoarding cash or going defensive. Chances are that it may need to hold on to its cash while it absorbs Adolor and anything else it is considering.

PDL BioPharma, Inc. (NASDAQ: PDLI) has been a dividend payer from its patent royalties, but some payments have been one-time payments until its most recent $0.15 payout for each of the past four quarters. The company also recently forecast a 5% revenue drop and investors are already braced for lower royalty payments. The company recently lost its CFO after only about three years on the job and we really do not like to see CFOs leave biohealth companies. Estimates are $1.18 EPS for 2011 and $1.38 EPS in 2012, but it has about $225 million in cash and liquidity versus a market cap of $867 million. The company may just stick with its current payout structure’s high yield as is until (or if) it can secure another large patent license.

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) is worth some $5.1 billion or so in market capitalization and is fresh off the news that it settled with Genentech over U.S. opthalmic sales of the eye drug EYLEA with a patent case still brewing, but with Regeneron agreeing to pay out $60 million if sales reach $400 million and it will pay royalties out as well. With cash and liquidity of near $500 million at then end of September we think it is a bit premature to ask this one to start shelling out its cash to shareholders yet, considering it is still expected to have a wide loss in 2012.

Vertex Pharmaceuticals Inc. (NASDAQ: VRTX) is so far off of highs now that it seems unlikely investors are expecting much on the dividend front. The company is back on the path of growth after some changes and stumbles, and now its market cap is almost $7 billion. With this one it just feels too soon to expect any dividends in reality. We could analyze all we want, but its new revenue growth is challenged by a cash balance of just over $800 million versus $400 million in long-term debt. What is interesting is that Vertex’s $0.30 EPS expected for 2011 is expected to be $4.55 EPS in 2012. It had a loss of $3.77 EPS in 2010. Maybe after another year or so we can evaluate its future dividend strategy.

After reviewing the great biotech sector’s larger components, it sure does not sound like many other than Biogen Idec Inc. (NASDAQ: BIIB) are really new prime-time dividend candidates for 2012, other than the high payout of PDL BioPharma, Inc. (NASDAQ: PDLI).

JON C. OGG

Filed under: Biotech, Dividend, Drug companies, Healthcare, Shareholder Issues Tagged: ALXN, AMGN, BIIB, CBST, CELG, MRK, PDLI, PFE, REGN, VRTX, VRUS

24/7 Wall St. Closing Bell (AAPL, DV, MS, QCOM, TGT, WDC, HAST, TECD, TSN, HPQ, TSL, CSIQ, JKS, JASO, LDK, STP, LNKD, VRUS, GILD, FMCN, GEDU, REGN, Z)

Paul Ausick — Mon, 21 Nov 2011 21:08:28 +0000

Stock prices plunged this morning and spent most of the day trading way down. The DJIA hovered around -300 points for most of the day, while the NASDAQ was off around -50 points and the S&P 500 wobbled around -30 points for most of the day. Today’s report on existing home sales was better than expected, but that was not enough to encourage investors to buy. Continuing concern over the state of Europe and a nearly unanimous belief that the US Congress’s super committee would fail to reach an agreement far outweighed any good news in the first half of the day. In mid-afternoon, Atlanta Federal Reserve president William Lockhart said that he did not foresee a second US recession, and put the likelihood of another recession at 30%. That gave the markets a bit of a bounce late in the day. Gold is down nearly -3%, at $1,674.40 and oil is down slightly to just under $97/barrel.

The unofficial closing bells put the DJIA down about 248 points to 11,547.23 (-2.11%), the NASDAQ fell more than 49 points (-1.92%) to 2,523.14, and the S&P 500 fell -1.86% or more than 22 points to 1,192.99.

There were several analyst upgrades and downgrades today, including Apple Inc. (NASDAQ: AAPL) reiterated as ‘buy’ with a $500 price target at Credit Suisse. Other ratings actions included DeVry, Inc. (NYSE: DV) cut to ‘underperform’ and ‘Bear of the Day’ at Zack’s; Morgan Stanley (NYSE: MS) raised to ‘buy’ at Argus; Qualcomm Inc. (NASDAQ: QCOM) reiterated as ‘buy’ with a $72 price target at Argus; Target Corp. (NYSE: TGT) cut to ‘neutral’ at JPMorgan; and Western Digital Corp. (NYSE: WDC) raised to ‘overweight’ at Barclays.

Here are today’s big post-earnings news reactions with prices during the last half-hour of trading: Hastings Entertainment Inc. (NASDAQ: HAST) was down more than -13%, at $1.65, after posting a new 52-week low of $1.55; Tech Data Corp. (NASDAQ: TECD) was down -0.9%, at $47.47, and Tyson Foods Inc. (NYSE: TSN) was up about 0.3% at $19.51. We took a closer look at Tech Data’s earnings earlier today.

After markets close today and before they re-open for tomorrow, there will be an avalanche of earnings reports. Perhaps the most closely watched will be Hewlett-Packard Co. (NYSE: HPQ) and a half dozen Chinese solar PV makers: JinkoSolar Holding Solar Co. Ltd. (NYSE: JKS), Trina Solar Ltd. (NYSE: TSL), Canadian Solar Inc. (NASDAQ: CSIQ), JA Solar Holdings Co. Ltd. (NASDAQ: JASO), LDK Solar Co. Ltd. (NYSE: LDK), and Suntech Power Holdings Co. Ltd. (NYSE: STP). Shares in all these solar makers are down today, as investors anticipate the bad news that’s coming.

Several other standouts from today are as follows…

LinkedIn Corp. (NASDAQ: LNKD) is down more than -4%, at $68.95. The company’s 180-day lock-up period ended today, adding another 24 million shares of the company available for sale. LinkedIn tied up another 56 million shares for an additional 90 days or the damage could have been worse.

Pharmasset, Inc. (NASDAQ: VRUS) is up nearly 85%, at $134.03, after hitting a new 52-week high of $135. The company has agreed to be acquired by Gilead Sciences Inc. (NASDAQ: GILD) for $11 billion.

Gilead Sciences, Inc. (NASDAQ: GILD) is down nearly -9.7%, at $36.02, after posting a new 52-week low of $34.45. Investors tend to believe that Gilead is paying too much for Pharmasset.

Focus Media Holding Ltd. (NASDAQ: FMCN) is down nearly -39%, at $15.56. The Chinese advertising company is the target of a report by short-selling firm Muddy Waters alleging that Focus Media has signififcantly overstated the number of screens in its LCD network.

Global Education and Technology Group Ltd. (NASDAQ: GEDU) is up more than 97%, at $10.60, after posting a new 52-week high of $10.70. The company is being acquired by Pearson plc, owner of the Financial Times newspaper and other media properties.

Regeneron Pharmaceuticals Inc. (NASDAQ: REGN) is up more than 10%, at $55.02. The company received USDA approval for its eye drug Eylea.

Zillow, Inc. (NYSE: Z) is down more than -13%, at $23.52, after posting a new 52-week low of $22.55. There is no specific news about the company, but, like LinkedIn, a pile of shares will be available on the market when the company’s lock-up period ends in about another two months.

Stay tuned for Tuesday. In addition to the earnings reports we’ve mentioned, here’s a list of other noteworthy events (all times Eastern):

7:45 a.m. – International Council of Shopping Centers-Goldman Sachs retail sales report
8:30 a.m. – US third-quarter GDP report revisions
8:30 a.m. – BEA corporate profits report
2:00 p.m. – Federal Open Market Committee minutes released

Paul Ausick

Filed under: HI/LOW, Market Close Tagged: AAPL, CSIQ, DV, FMCN, GEDU, GILD, HAST, HPQ, JASO, JKS, LDK, LNKD, MS, QCOM, REGN, STP, TECD, TGT, TSL, TSN, VRUS, WDC, Z

Top Analyst Upgrades & Downgrades (CRL, CSCO, GLW, EXPE, PPDI, RL, PCLN, REGN, RIMM, RPM, BID, TSO, TIVO, URI)

Administrator — Fri, 09 Sep 2011 12:06:01 +0000

These are some of this Friday’s top analyst upgrades, downgrades, and initiations seen having an impact from Wall Street research calls.

Charles River Laboratories International, Inc. (NYSE: CRL) Started as Hold at Citigroup.
Cisco Systems, Inc. (NASDAQ: CSCO) Raised to Sector Perform at RBC.
Corning Inc. (NYSE: GLW) Maintained Buy but cut target to $25 at BofA/ML.
Expedia Inc. (NASDAQ: EXPE) Started as Outperform at Wedbush.
Pharmaceutical Product Development Inc. (NASDAQ: PPDI) Started as Hold at Citigroup.
Polo Ralph Lauren (NYSE: RL) named Bull of the Day at Zacks.
Priceline.com Incorporated (NASDAQ: PCLN) Started as Outperform at Wedbush.
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) Cut to Underperform at BofA/ML.
Research In Motion Limited (NASDAQ: RIMM) Cut to Underperform at Jefferies.
RPM International (NYSE: RPM) Raised to Neutral at Credit Suisse.
Sotheby’s Inc. (NYSE: BID) called the value stock of the day at Zacks.
Tesoro Corporation (NYSE: TSO) Cut to Sell at Goldman Sachs.
TiVo Inc. (NASDAQ: TIVO) Started as Buy at Brean Murray.
United Rentals, Inc. (NYSE: URI) Started as Outperform at Credit Suisse.

JON C. OGG

Filed under: Analyst Calls Tagged: BID, CRL, CSCO, EXPE, GLW, PCLN, PPDI, REGN, RIMM, RL, RPM, TIVO, TSO, URI

Top Analyst Upgrades & Downgrades (BGFV, BIIB, ETN, HIG, HGSI, P, REGN, RIMM, RUE, SQNM, VMW, INT)

Administrator — Fri, 26 Aug 2011 12:18:17 +0000

These are some of the top analyst upgrades, downgrades, and initiations seen from Wall Street research calls this Friday morning.

Big 5 Sporting Goods (NASDAQ: BGFV) named Bear of the Day at Zacks.
Biogen Idec Inc. (NASDAQ: BIIB) Reiterated Buy with $115 target at Argus.
Eaton Corporation (NYSE: ETN) named as Bull of the Day at Zacks.
Hartford Financial Services Group Inc. (NYSE: HIG) Reiterated Buy but cut target to $26 at Argus.
Human Genome Sciences Inc. (NASDAQ: HGSI) Maintained Outperform but cut target to $27 at Credit Suisse.
Pandora Media, Inc. (NYSE: P) Reiterated Buy and raised target to $19 at BofA/ML.
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) Cut to Hold at Citigroup.
Research in Motion Ltd. (NASDAQ: RIMM) Raised to Buy at Stern Agee.
rue21, Inc. (NASDAQ: RUE) Raised to Buy at BofA/ML.
Sequenom Inc. (NASDAQ: SQNM) Started as Outperform at William Blair.
VMware Inc. (NYSE: VMW) Raised to Outperform at Pacific Crest.
World Fuel Services Corporation (NYSE: INT) named Value stock of the day at Zacks.

JON C. OGG

Filed under: Analyst Calls Tagged: BGFV, BIIB, ETN, HGSI, HIG, INT, P, REGN, RIMM, RUE, SQNM, VMW